DeepRNAi: Predicting on- and off-target siRNA activity and establishing a benchmark

Small interfering RNAs (siRNAs) silence target genes through RISC-mediated hybridization and cleavage, but can silence unintended transcripts and cause toxicity or complicate regulatory approval. In drug development, empirical assessment by qPCR and RNA-seq is slow, forces early candidate prioritization, and is limited by available species- and genome-appropriate cell models. While extensive empirical screening remains standard practice, there is a significant opportunity for modern AI methods to change this paradigm. We introduce DeepRNAi, a deep learning model that accurately predicts on- and off-target knockdown from siRNA and mRNA sequence. Trained on 16 million siRNA-transcript pairs from 2,031 siRNAs designed to interrogate known siRNA failure modes, and incorporating transcript context from biological foundation models, DeepRNAi is the first in silico method that approaches experimental accuracy. It generalizes across cell models, transcripts, genomes and species, and in a small study distinguishes approved therapeutics from hepatotoxic candidates. The value of DeepRNAi for prioritizing better candidates up front improving likelihood of success later in development is evidenced by a genome-wide survey of 24.4 million siRNAs targeting 7,946 genes, which indicates that 90.1% of the 100 most potent siRNAs have at least some off-target concerns. To support the community, we are publishing a training and benchmark dataset containing 1.84 million siRNA-transcript pairs from 240 siRNAs.

Authors

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.12.766311
Primary Topic
RNA Interference and Gene Delivery
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

DeepRNAi: Predicting on- and off-target siRNA activity and establishing a benchmark

Brendan J. Frey, Nathan H. Lazar, Brodie Fischbacher, Bhargav Kanuparthi et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
RNA Interference and Gene Delivery
preprint

DeepRNAi: Predicting on- and off-target siRNA activity and establishing a benchmark

Brendan J. Frey, Nathan H. Lazar, Brodie Fischbacher, Bhargav Kanuparthi, K. Arseneault, Sapna Johnson, Mykhaylo Slobodyanyuk, Noah J Lorincz‐Comi, Tammy T.Y. Lau, Emma Bohn, Albi Celaj, Nicolas Y. Masse, Roujia Li, Gregory R. Hoffman, Jeff A. Wintersinger, Christopher B. Cole, Scott D. Findlay, Helen Zhu, Wangting Lu, Jonathan La, Vivian S. Chu
preprint en

Abstract

Small interfering RNAs (siRNAs) silence target genes through RISC-mediated hybridization and cleavage, but can silence unintended transcripts and cause toxicity or complicate regulatory approval. In drug development, empirical assessment by qPCR and RNA-seq is slow, forces early candidate prioritization, and is limited by available species- and genome-appropriate cell models. While extensive empirical screening remains standard practice, there is a significant opportunity for modern AI methods to change this paradigm. We introduce DeepRNAi, a deep learning model that accurately predicts on- and off-target knockdown from siRNA and mRNA sequence. Trained on 16 million siRNA-transcript pairs from 2,031 siRNAs designed to interrogate known siRNA failure modes, and incorporating transcript context from biological foundation models, DeepRNAi is the first in silico method that approaches experimental accuracy. It generalizes across cell models, transcripts, genomes and species, and in a small study distinguishes approved therapeutics from hepatotoxic candidates. The value of DeepRNAi for prioritizing better candidates up front improving likelihood of success later in development is evidenced by a genome-wide survey of 24.4 million siRNAs targeting 7,946 genes, which indicates that 90.1% of the 100 most potent siRNAs have at least some off-target concerns. To support the community, we are publishing a training and benchmark dataset containing 1.84 million siRNA-transcript pairs from 240 siRNAs.

bioRxiv (Cold Spring Harbor Laboratory)
Good health and well-being
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon